Peter S. Greenleaf - 20 Feb 2026 Form 4 Insider Report for Aurinia Pharmaceuticals Inc. (AUPH)

Signature
/s/ Peter S. Greenleaf
Issuer symbol
AUPH
Transactions as of
20 Feb 2026
Net transactions value
-$1,442,462
Form type
4
Filing time
23 Feb 2026, 16:07:03 UTC
Previous filing
05 Jan 2026
Next filing
03 Mar 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Greenleaf Peter Chief Executive Officer, Director #140, 14315-118 AVENUE, EDMONTON, ALBERTA, CANADA /s/ Peter S. Greenleaf 23 Feb 2026 0001363683

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AUPH Common Stock Tax liability $1,442,462 -100,171 -5.4% $14.40 1,744,866 20 Feb 2026 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld to satisfy tax withholding obligations upon the vesting of restricted stock units.